Search results
Order by most recent / most popular / relevance
Results: 1-10 of 167
Judicial review brought outside time period and no vested right to NOC
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This decision relates to the consideration by the Minister of Health of Apotex’ submission for a Notice of Compliance (NOC) for omeprazole magnesium
Definition of “innovative drug” does not include variations
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This is an appeal by Takeda of a decision of the Court, in which the Court upheld the decision of the Minister of Health to refuse to list Takeda’s
Trial Judge's findings of anticipation and obviousness upheld on appeal
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This is an appeal of a patent infringement decision. The Court found the patent invalid for anticipation and obviousness. The Court of Appeal held
Hershkovitz v. Tyco safety Products Canada Ltd
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 4 2010
Hershkovitz appealed a decision of the Federal Court holding that its patent was invalid
Picard v. Commissioner of Patents
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 4 2010
This is an official translation of a decision released in January 20, 2010
Eli Lilly Canada v. Novopharm Limited
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 4 2010
The Court of Appeal overturned the decision of the trial judge which held that the patent was invalid
Pfizer v. Ratiopharm
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 11 2010
The Court of Appeal dismissed Pfizer's appeal from a Trial Judge decision finding the patent at issue to be invalid
Divisional patent application can be filed by applicant not named in original application
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 15 2010
This case is a judicial review of a decision of the Commissioner of Patents where recognition of a patent application as a divisional application was denied
Novo Nordisk v. Cobalt
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 18 2010
The Trial Judge dismissed an application seeking to prohibit Cobalt from coming to market with its generic repaglinide product
Generic association does not have standing to challenge listing on register of innovative drugs
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 21 2010
The Canadian Generic Pharmaceutical Associate (CGPA) brought a judicial review application in respect of the listing of Avamys on the Register of Innovative Drugs (Register
Current Search
- Workarea - Patents
- Workarea - Litigation
- Author - Beverley Moore